Real-time Stock quotes, portfolio, LIVE TV and more.
Aug 02, 2012, 07.51 PM IST
Glenmark Pharma has disappointed the street by its first quarter numbers as consolidated net profit fell by 62.5% year-on-year to Rs 78.3 crore in the quarter, which was far lower than forecast of Rs 131 crore.
Consolidated net sales increased 19.8% to Rs 1,040 crore from Rs 868 crore year-on-year, which was almost in-line with analysts' expectations of Rs 1,028 crore.
The share rose just 0.36% to close at Rs 387.60 amid huge volumes.
Tags: Glenmark Pharma
Action in Glenmark Pharma
May 23 2013, 16:33
- in Asian markets
May 23 2013, 09:33
- in Technicals